Brief: ATG Fund II Llc Reports Stake In Forte Biosciences, Says Shares Were Undervalued

Forte Biosciences

04/08/2022 23:09

Aug 4 (Reuters) - ATG Fund II Llc:
    * ATG FUND II LLC REPORTS 9.9% STAKE IN FORTE BIOSCIENCES
INC AS
OF JULY 25 - SEC FILING
    * ATG FUND II LLC - PURCHASED FORTE BIOSCIENCES' SHARES OF
COMMON
STOCK BASED ON BELIEF THAT THE SHARES, WHEN PURCHASED, WERE
UNDERVALUED
    * ATG FUND II LLC -  PREVIOUSLY EXPRESSED DISSATISFACTION
WITH
STRATEGIC DIRECTION OF FORTE BIOSCIENCES, INCLUDING FORTE'S
INTRODUCTION OF POISON PILL.
    * ATG FUND II LLC - INTEND TO ENGAGE IN DISCUSSIONS WITH
FORTE
BIOSCIENCES INC REGARDING THE POTENTIAL ALTERNATIVES


 ((Reuters.Briefs@thomsonreuters.com;))